Literature DB >> 26442676

Bloodstream infections in pediatric patients with acute leukemia: Emphasis on gram-negative bacteria infections.

Fu-Chun Kuo1, Shih-Min Wang2, Ching-Fen Shen1, Yun-Ju Ma1, Tzong-Shiann Ho3, Jiann-Shiuh Chen1, Chao-Neng Cheng1, Ching-Chuan Liu4.   

Abstract

BACKGROUND/
PURPOSE: Acute leukemia is the most common pediatric hematological malignancy. Bloodstream infections (BSIs) are severe complications in these patients during chemotherapy. This study aims to explore clinical features, laboratory, and microbiological characteristics of BSIs in acute leukemic children.
METHODS: Patients aged < 18 years, diagnosed with acute myeloid leukemia or acute lymphocytic leukemia with BSIs from January 2004 to December 2013 were enrolled. BSIs was defined as positive isolate(s) of blood culture and associated with clinical findings. Clinical presentations, demographic features, and microbiological findings were retrospectively reviewed.
RESULTS: In total, 126 isolates of 115 episodes of BSIs were identified from 69 patients (acute lymphocytic leukemia 56; acute myeloid leukemia 13). Gram-negative bacteria (GNB), gram-positive cocci, and fungi constituted 56.3%, 42.3%, and 2.4% of the pathogens, respectively. Eighty-three and a half percent of BSIs occurred along with neutropenia, and 73% had severe neutropenia. GNB was the leading pathogen of BSIs. The major GNBs were Escherichia coli, Klebsiella pneumonia, and Pseudomonas aeruginosa. White blood cell counts, absolute neutrophil counts, and platelet counts were significantly lower in patients of BSIs caused by GNB than gram-positive cocci. Plasma level of C-reactive protein was significant high in patients of GNB BSIs (179.8 mg/L vs. 127.2 mg/L; p = 0.005). Eighty-two percent of patients of E. coli, K. pneumonia, and P. aeruginosa BSIs had sepsis related organ failure or organ dysfunction. P. aeruginosa BSIs had the highest case-mortality (40%).
CONCLUSION: Neutropenia was the major risk factor of BSIs in pediatric leukemic patients. BSIs of GNB were associated with severe neutropenia, systemic inflammatory responses, and high mortality.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  acute leukemia; bloodstream infection; children; gram-negative bacteria

Mesh:

Year:  2015        PMID: 26442676     DOI: 10.1016/j.jmii.2015.08.013

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  9 in total

1.  Treatment-Related Mortality From Infectious Complications in an Acute Leukemia Clinic.

Authors:  Jorge Torres-Flores; Ramiro Espinoza-Zamora; Jorge Garcia-Mendez; Eduardo Cervera-Ceballos; Alejandro Sosa-Espinoza; Nidia Zapata-Canto
Journal:  J Hematol       Date:  2020-11-06

2.  Antibiotic-resistant organisms establish reservoirs in new hospital built environments and are related to patient blood infection isolates.

Authors:  Kimberley V Sukhum; Erin P Newcomer; Candice Cass; Meghan A Wallace; Caitlin Johnson; Jeremy Fine; Steven Sax; Margaret H Barlet; Carey-Ann D Burnham; Gautam Dantas; Jennie H Kwon
Journal:  Commun Med (Lond)       Date:  2022-06-01

3.  Clinical Characteristics of Bloodstream Infections in Pediatric Acute Leukemia: A Single-center Experience with 231 Patients.

Authors:  Jia-Feng Yao; Nan Li; Jin Jiang
Journal:  Chin Med J (Engl)       Date:  2017-09-05       Impact factor: 2.628

4.  Phenotypic screening and molecular characterization of carbapenemase-producing Gram-negative bacilli recovered from febrile neutropenic pediatric cancer patients in Egypt.

Authors:  Noha A Kamel; Wafaa N El-Tayeb; Mona R El-Ansary; Mohamed T Mansour; Khaled M Aboshanab
Journal:  PLoS One       Date:  2018-08-29       Impact factor: 3.240

5.  Bacterial profile and antimicrobial susceptibility patterns in cancer patients.

Authors:  Minichil Worku; Gizeaddis Belay; Abiye Tigabu
Journal:  PLoS One       Date:  2022-04-15       Impact factor: 3.752

6.  Alarming Antibiotic Resistance in Pediatric Oncology Patients: A Three-Year Prospective Cohort Study from Oman.

Authors:  Abeer Al Battashi; Bishara Al Harrassi; Nawal Al Maskari; Hilal Al Hashami; Salah Al Awaidy
Journal:  Infect Drug Resist       Date:  2022-07-25       Impact factor: 4.177

7.  Induction therapy for acute lymphoblastic leukemia: incidence and risk factors for bloodstream infections.

Authors:  Rosângela Aparecida Mendes Silva; Regina Maria Holanda de Mendonça; Simone Dos Santos Aguiar; Júlia Cervellini Yajima; Fernando Augusto Lima Marson; Silvia Regina Brandalise; Carlos Emílio Levy
Journal:  Support Care Cancer       Date:  2021-08-07       Impact factor: 3.603

8.  Prevalence of multidrug-resistant Gram-negative pathogens isolated from febrile neutropenic cancer patients with bloodstream infections in Egypt and new synergistic antibiotic combinations.

Authors:  Sally Tohamy Tohamy; Khaled Mohamed Aboshanab; Hadir Ahmed El-Mahallawy; Mona R El-Ansary; Salwa Selim Afifi
Journal:  Infect Drug Resist       Date:  2018-05-25       Impact factor: 4.003

Review 9.  Update on Febrile Neutropenia in Pediatric Oncological Patients Undergoing Chemotherapy.

Authors:  Federica Cennamo; Riccardo Masetti; Prisca Largo; Alberto Argentiero; Andrea Pession; Susanna Esposito
Journal:  Children (Basel)       Date:  2021-11-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.